Articles Tagged: Cure
March 30, 2009 | Category: News
Christopher & Dana Reeve Foundation expresses appreciation to Congressional co-sponsors for passing first legislation specific to the paralysis community
SHORT HILLS, N.J., March 30 /PRNewswire-USNewswire/ — The Christopher & Dana Reeve Foundation, the national, non-profit organization dedicated to finding cures and treatments for spinal cord injuries and improving the lives of people living with paralysis, applauds President Obama for signing the Omnibus Public Lands Bill. Passed by the U.S. House of Representatives on March 25 and the U.S. Senate on January 15, Title XIV of the Bill contains the Christopher and Dana Reeve Paralysis Act. The Act was named for the late Christopher Reeve and his wife Dana, whose courage and grace in the face of adversity, coupled with their extraordinary activism, were an inspiration to millions around the world. Continue Reading »
March 28, 2009 | Category: News
DaVinci Biosciences, in collaboration with Luis Vernaza Hospital in Ecuador, have announced the publication of study results demonstrating the safety and feasibility of its acute and chronic spinal cord injury treatment platform in Cell Transplantation, a peer-reviewed journal focused on regenerative medicine. The study demonstrates that administering adult autologous bone marrow derived stem cells via multiple routes is feasible, safe, and most importantly, improves the quality of life for both acute and chronic spinal cord injury (SCI) patients. Continue Reading »
March 23, 2009 | Category: News
UCI scientist is behind the field’s first human clinical trial
Irvine, Calif., UC Irvine’s Hans Keirstead – the neurobiologist behind what will be the world’s first human embryonic stem cell clinical trial – will brief Congress on the state of the field 10-11:30 a.m. Tuesday, March 24, in Washington, D.C.
Keirstead will join Robert Klein, a spinal-cord-injury research advocate, and Thomas Okarma, Geron Corp. president and chief executive officer, for the briefing, in Room H-122 of the Capitol. Geron will conduct the clinical trial for Keirstead’s acute-spinal-cord-injury therapy. Continue Reading »
March 21, 2009 | Category: News
Hope—and anxiety—run high as the first clinical trial of embryonic-stem-cell therapy begins this summer.
Six weeks before the hoopla over President Barack Obama’s executive order lifting restrictions on embryonic-stem-cell research, Hans Keirstead, a scientist at the University of California, Irvine, was already sipping champagne. In 2005 Keirstead had published a study showing that a therapy derived from human embryonic stem cells could make partially paralyzed rats walk. Continue Reading »
March 19, 2009 | Category: News
Yadong Wang, assistant professor at the Coulter Department of Biomedical Engineering of Georgia Tech and Emory University, and graduate student Christiane Gumera have developed a potentially promising strategy for encouraging the regeneration of damaged central nervous system neurons. Gumera points to a fluorescence image that indicates the presence of proteins required for nerve regeneration.
MANILA, Philippines – When Christiane Gumera left Manila in 1988 for the United States, she was a sickly child constantly having breathing difficulties. Today, she is a scientist helping a team of medical researchers develop a cure for the disabled. Continue Reading »
March 17, 2009 | Category: News
On Wednesday, March 18, the Understanding Disabilities program will present Travis Roy as a speaker for the Coolidge and Parker Middle Schools. Roy is the Boston University hockey player who, 11 seconds into his first collegiate hockey game in the fall of 1995, was in an accident that cracked his fourth and fifth cervical vertebra, leaving him paralyzed from the neck down.
Roy returned to Boston University less than a year after his accident and graduated four years later with a degree in public relations. In 1997, with the help of sportswriter E.M. Swift, he wrote his autobiography titled “Eleven Seconds,” which tells the story of his accident and rehabilitation. His book was recently updated and is currently in its sixth printing. Continue Reading »
March 13, 2009 | Category: News
Washington: Injecting a patient’s own bone marrow-derived stem cells
into the spinal column using multiple routes can be an effective treatment for spinal cord injury (SCI), say researchers.
Scientists from DaVinci Biosciences, Costa Mesa, California, and Hospital Luis Vernaza in Ecuador say that such a treatment can return some quality of life for SCI patients without serious adverse events. Continue Reading »
March 10, 2009 | Category: News
As President Barack Obama eased restrictions on embryonic stem cell research Monday, South Florida scientists said they will pursue the controversial research in their labs as they look for cures.
For more than a decade, Dr. Dalton Dietrich has worked in a lab at the University of Miami Medical School, trying to unlock the secrets of spinal-cord injury and paralysis.
He got a new tool Monday when President Barack Obama lifted a ban on federal funding for embryonic stem cell research. Continue Reading »
March 10, 2009 | Category: News
A bill that would limit stem cell research in Georgia and define a living human embryo as a person, has a good chance of coming before the state Senate for a vote Thursday.
The “Ethical Treatment of Human Embryos Act” was approved in a Georgia legislative committee Monday, the same day that President Obama lifted Bush administration restrictions on federal funding of embryonic stem cell research. Continue Reading »
March 9, 2009 | Category: News
WASHINGTON — While lifting the Bush administration’s restrictions on federally financed human embryonic stem cell research, President Obama intends to avoid the thorniest question in the debate: whether taxpayer dollars should be used to experiment on embryos themselves, two senior administration officials said Sunday.
The officials, who provided details of the announcement Mr. Obama will make Monday at the White House, said the president would leave it to Congress to determine whether the long-standing legislative ban on federal financing for human embryo experiments should also be overturned. Continue Reading »